DODGX
Price
$16.99
Change
-$0.04 (-0.23%)
Updated
Nov 18 closing price
Net Assets
118.72B
IEDRX
Price
$12.00
Change
-$0.01 (-0.08%)
Updated
Nov 18 closing price
Net Assets
793.06M
Interact to see
Advertisement

DODGX vs IEDRX

Header iconDODGX vs IEDRX Comparison
Open Charts DODGX vs IEDRXBanner chart's image
Dodge & Cox Stock I
Price$16.99
Change-$0.04 (-0.23%)
VolumeN/A
Net Assets118.72B
Voya Large Cap Value R
Price$12.00
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets793.06M
DODGX vs IEDRX Comparison Chart in %
View a ticker or compare two or three
VS
DODGX vs. IEDRX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DODGX is a Hold and IEDRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DODGX has more cash in the bank: 119B vs. IEDRX (793M). DODGX pays higher dividends than IEDRX: DODGX (1.34) vs IEDRX (0.74). DODGX was incepted earlier than IEDRX: DODGX (61 years) vs IEDRX (14 years). IEDRX (1.36) is less costly to investors than DODGX (0.51). IEDRX is a more actively managed with annual turnover of: 100.00 vs. DODGX (15.00). IEDRX has a lower initial minimum investment than DODGX: IEDRX (0) vs DODGX (2500). DODGX annual gain was more profitable for investors over the last year : 22.30 vs. IEDRX (-7.74). DODGX return over 5 years is better than : 255.07 vs. IEDRX (10.66).
DODGXIEDRXDODGX / IEDRX
Total Expense Ratio0.511.3538%
Annual Report Gross Expense Ratio0.511.3638%
Fund Existence61 years14 years-
Gain YTD28.1038.532329%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets119B793M15,006%
Annual Yield % from dividends1.340.74182%
Returns for 1 year22.30-7.74-288%
Returns for 3 years138.055.882,346%
Returns for 5 years255.0710.662,393%
Returns for 10 years426.8715.742,713%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCAB1.230.21
+20.59%
BioAtla
ZBIO36.270.39
+1.09%
Zenas Biopharma Inc.
CCK95.200.18
+0.19%
Crown Holdings
HBCP52.480.05
+0.10%
Home Bancorp
DRMA2.67-0.17
-5.99%
Dermata Therapeutics Inc